Washington Trust Bank’s Regeneron Pharmaceuticals REGN Stock Holding History

Washington Trust Bank’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-2	Closed	-$1K	–	832
2017 Q4	$1K	Buy	+2	New	+$810	﹤0.01%	710
2017 Q1	–	Sell	-6	Closed	-$2K	–	903
2016 Q4	$2K	Sell	6 -6	-50%	-$2.28K	﹤0.01%	688
2016 Q3	$5K	Buy	+12	New	+$4.81K	﹤0.01%	606
2014 Q4	–	Sell	-10	Closed	-$4K	–	872
2014 Q3	$4K	Hold	10	–	–	﹤0.01%	755
2014 Q2	$3K	Hold	10	–	–	﹤0.01%	819
2014 Q1	$3K	Buy	+10	New	+$3.08K	﹤0.01%	778

Other funds holding REGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Washington Trust Bank's REGN Position: Q1 2018 in Review

Washington Trust Bank sold out of Regeneron Pharmaceuticals (REGN) in Q1 2018, closing a stake of 2 shares — an estimated $1K sold.

Washington Trust Bank first reported a position in REGN in Q1 2014 and held it in 6 quarters. The position peaked at $5K in Q3 2016. 619 funds tracked by Wall St. Rank hold REGN as of Q1 2018.

Washington Trust Bank reported no remaining Regeneron Pharmaceuticals position as of Q1 2018 after selling out during the quarter.
Washington Trust Bank sold 2 Regeneron Pharmaceuticals shares in Q1 2018, an estimated $1K.
Washington Trust Bank first reported a position in Regeneron Pharmaceuticals in Q1 2014 and held it in 6 quarters.
Washington Trust Bank's Regeneron Pharmaceuticals position peaked at $5K in Q3 2016.
619 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2018.

Based on Washington Trust Bank's 13F filing for Q1 2018, filed 3 Apr 2018.